James Momtazee, Director at Jazz Pharmaceuticals, holds 92.43K shares in Roivant Sciences (Ticker: ROIV), holds 88.49K shares in BridgeBio Pharma (Ticker: BBIO), holds 3.52K shares in PRA Health Sciences (Ticker: PRAH).
James Momtazee latest transaction was an Uninformative Sell of $37.04K.
What was James Momtazee's most profitable transaction?
James Momtazee’s most profitable transaction was an Informative Buy of BBIO stock on January 3, 2022. The return on the trade was -58.20%.
What is James Momtazee's role in Jazz Pharmaceuticals?
James Momtazee's role in Jazz Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.